Health-related quality of life among Koreans with chronic respiratory disease

International Journal of Tuberculosis and Lung Disease

Volumn 13, Issue 5, 2009, Pages 580-586

  Oh, E G ^a   Bang, S Y ^b   Kim, Y S ^a   Park, M S ^a   Kim, S K ^a  

^a Yonsei University   (South Korea)

^b Joongbu University   (South Korea)

Author keywords

Chronic respiratory disease; Mood; Quality of life; Respiratory symptoms; Self efficacy

Indexed keywords

BETA ADRENERGIC RECEPTOR STIMULATING AGENT; BRONCHODILATING AGENT; CHOLINERGIC RECEPTOR BLOCKING AGENT; STEROID;

ADULT; AGED; ANXIETY; ARTICLE; CHEST TIGHTNESS; CHRONIC OBSTRUCTIVE LUNG DISEASE; CHRONIC RESPIRATORY TRACT DISEASE; CORRELATIONAL STUDY; COUGHING; CROSS-SECTIONAL STUDY; DEPRESSION; DYSPNEA; EXERCISE; FATIGUE; FEMALE; FORCED EXPIRATORY VOLUME; HUMAN; KOREA; LUNG FUNCTION; MAJOR CLINICAL STUDY; MALE; MOOD; OUTPATIENT DEPARTMENT; OXYGEN THERAPY; PATH ANALYSIS; PRIORITY JOURNAL; QUALITY OF LIFE; QUESTIONNAIRE; RESPIRATORY TRACT DISEASE; SELF CONCEPT; SLEEP DISORDER; SPUTUM; SYMPTOM; UNIVERSITY HOSPITAL;

ADULT; AGED; AGED, 80 AND OVER; CHRONIC DISEASE; CROSS-SECTIONAL STUDIES; FEMALE; FORCED EXPIRATORY VOLUME; HEALTH STATUS; HUMANS; KOREA; MALE; MIDDLE AGED; PREVALENCE; QUALITY OF LIFE; QUESTIONNAIRES; RESPIRATORY TRACT DISEASES;

EID: 67649516319     PISSN: 10273719     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. Pauwels R A, Buist A S, Calverley P M A, Jenkins C R, Hurd S S, on behalf of the GOLD Scientific Committee. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. NHLBI/WHO Global Initiative for Chronic Obstructive Lung Disease (GOLD) workshop summary. Am J Respir Crit Care Med 2001; 163: 1256-1276.
2. Kim D S, Kim Y S, Jung K S, et al. Prevalence of chronic obstructive pulmonary disease in Korea: a population-based spirometry survey. Am J Respir Crit Care Med 2005; 172: 842-847.
3. Korea National Statistical Office. The average life span and mortality. Seoul, Korea: Korea National Statistical Office, 2003. http://www.nso.go.kr/ eng2006/emain/index.html Accessed December 2007.
4. Voll-Aanerud M, Eagan T M, Wentzel-Larsen T, Gulsvik A, Bakke P S. Respiratory symptoms, COPD severity and healthrelated quality of life in a general population sample. Respir Med 2008; 102: 399-406.
5. Schrier A C, Dekker F W, Kaptein A A, Dijkman J H. Quality of life in elderly patients with chronic non-specific lung disease seen in family practice. Chest 1990; 98: 894-899.
6. Graydon J E, Ross E, Webster P M, Goldstein R S, Avendano M. Predictors of functioning of patients with chronic obstructive pulmonary disease. Heart Lung 1995; 24: 369-375.
7. Weaver T E, Narsavage G L. Physiological and psychological variables related to functional status in chronic obstructive pulmonary disease. Nurs Res 1992; 41: 286-291.
8. Carrasco Garrido P, de Miguel Díez J, Rejas Gutiérrez J, et al. Negative impact of chronic obstructive pulmonary disease on the health-related quality of life of patients. Results of the EPIDEPOC study. Health Qual Life Outcomes 2006; 23: 31.
9. Guyatt G H, Townsend M, Keller J, Singer J, Nogradi S. Measuring functional status in chronic lung disease: conclusions from a randomized control trial. Respir Med 1991; 85 (Suppl B): 17-21; discussion 33-37.
10. Alonso J, Ferrer M, Gandek B, et al. IQOLA Project Group. Health-related quality of life associated with chronic conditions in eight countries: results from the International Quality of Life Assessment (IQOLA) Project. Qual Life Res 2004; 13: 283-298.
11. Make B, Casaburi R. Is exercise important in chronic obstructive pulmonary disease? COPD 2007; 4: 185-189.
12. Jones P W, Bosh T K. Quality of life changes in COPD patients treated with salmeterol. Am J Respir Crit Care Med 1997; 155: 1283-1289.
13. Reis A L. Impact of chronic obstructive pulmonary disease on quality of life: the role of dyspnea. Am J Med 2006; 119: S12-S20.
14. Kapella M C, Larson J L, Patel M K, Covey M K, Berry J K. Subjective fatigue, influencing variables and consequences in chronic obstructive pulmonary disease. Nurs Res 2006; 55: 10-17.
15. Stage K B, Middelboe T, Stage T B, Sørensen C H. Depression in COPD-management and quality of life considerations. Int J Chron Obstruct Pulmon Dis 2006; 1: 315-320.
16. Cleland J A, Lee A J, Hall S. Associations of depression and anxiety with gender, age, health-related quality of life and symptoms in primary care COPD patients. Fam Pract 2007; 24: 217-223.
17. Kunik M E, Veazey C, Cully J A, et al. COPD education and cognitive behavioral therapy group treatment for clinically significant symptoms of depression and anxiety in COPD patients: a randomized controlled trial. Psychol Med 2007; 9: 1-12.
18. Lee R N, Graydon J E, Ross E. Effects on psychological wellbeing, physical status, and social support on oxygen-dependent COPD patients' level of functioning. Res Nurs Health 1991; 14: 323-328.
19. Ng T P, Niti M, Tan W C, Cao Z, Ong K C, Eng P. Depressive symptoms and chronic obstructive pulmonary disease: effect on mortality, hospital readmission, symptom burden, functional status, and quality of life. Arch Intern Med 2007; 167: 60-67.
20. Kara Ka$sLikçi M, Alberto J. Family support, perceived selfefficacy and self-care behaviour of Turkish patients with chronic obstructive pulmonary disease. J Clin Nurs 2007; 16: 1468-1478.
21. Leidy N K, Traver G A. Psychophysiologic factors contributing to functional performance in people with COPD: are there gender differences? Res Nurs Health 1995; 18: 535-546.
22. Guyatt G H, Berman L B, Townsend M, Pugsley S, Chambers LW. A measure of quality of life for clinical trials in chronic lung disease. Thorax 1987; 42: 773-778.
23. Mahler D A, Weinberg D H, Wells C K, Geinstein A R. The measurement of dyspnea. Contents, interobserver agreement and physiologic correlates of two new clinical indexes. Chest 1984; 85: 751-758.
24. Jones P W, Quirk F H, Baveystock C M. The St. George's Respiratory Questionnaire. Resp Med 1991; 85 (Suppl): 25-31.
25. Lenz E R, Pugh L C, Milligan R A, Gift A, Suppe F. The middlerange theory of unpleasant symptoms: an update. Adv Nurs Sci 1997; 19: 14-27.
26. American Thoracic Society. ATS statement: guidelines for the six-minute walk test. Am J Respir Crit Care Med 2002; 166: 111-117.
27. McNair D M, Lorr M, Droppleman L F. Manual for the profile of mood state. San Diego, CA, USA: Educational and Industrial Testing Service, 2002.
28. Sherer M, Maddux J, Mercandante B, Prentice-Dunn S, Jacobs B. The self-efficacy scale: construction and validation. Psychol Reports 1982; 51: 663-671.
29. Yeh M L, Chen H H, Liao Y C, Liao W Y. Testing the functional status model in patients with chronic obstructive pulmonary disease. J Adv Nurs 2004; 48: 342-350.
30. Hu J, Meek P. Health-related quality of life in individuals with chronic obstructive pulmonary disease. Heart Lung 2005; 34: 415-422.
31. Moody L, McCormick K, Williams A. Disease and symptom severity, functional status, and quality of life in chronic bronchitis and emphysema (CBE). J Behav Med 1990; 13: 297-306.
32. Weaver T E, Richmond T S, Narsavage G L. An explanatory model of functional status in chronic obstructive pulmonary disease. Nurs Res 1997; 46: 26-31.
33. Breslin E, van der Schans C, Breukink S, et al. Perception of fatigue and quality of life in patients with COPD. Chest 1998; 114:958-964.
34. Wilson I. Depression in the patient with COPD. Int J Chron Obstruct Pulmon Dis 2006; 1: 61-64.
35. Whittle H, Goldenberg D. Functional health status and instrumental activities of daily living performance in noninstitutionalized elderly people. J Adv Nurs 1996; 23: 220-227.